11. Assessment of the telomere length and its effect on the symptomatology of Parkinson's diseaseTina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek, 2021, original scientific article Keywords: Parkinson's disease, telomere length, levodopa treatment, telomere attrition, dementia Full text (file, 737,20 KB) This document has more files! More... |
12. Metabolic brain pattern in dementia with Lewy bodiesMatej Perovnik, Petra Tomše, Jan Jamšek, Chris Chengke Tang, David Eidelberg, Maja Trošt, 2022, original scientific article Keywords: dementia with Lewy bodies, Alzheimer’s disease, biomarker, metabolic brain imaging, FDG PET, network analysis, scaled subprofile model/principal component analysis, SSM/PCA Full text (file, 2,27 MB) This document has more files! More... |
13. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Full text (file, 279,78 KB) This document has more files! More... |
14. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, original scientific article Keywords: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT Full text (file, 1,14 MB) This document has more files! More... |
15. Zolpidem improves task-specific dystoniaKatarina Vogelnik Žakelj, Maja Trošt, Petra Tomše, Igor N. Petrović, Aleksandra Tomić Pešić, Saša Radovanović, Maja Kojović, 2024, original scientific article Keywords: zolpidem, writer's cramp, musician's dystonia, TMS, FDG-PET Full text (file, 3,15 MB) This document has more files! More... |
16. Pharmacogenetic markers of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek, 2019, doctoral dissertation Keywords: Parkinson's disease, pharmacogenetics, dopaminergic treatment, adverse events, genetic polymorphisms, personalized medicine, clinical-pharmacogenetic models Full text (file, 11,02 MB) |
|
|
|
|